These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

80 related items for PubMed ID: 9529309

  • 1. Biological dosimetry of bone marrow for incorporated yttrium-90.
    Goddu SM, Howell RW, Giuliani DC, Rao DV.
    J Nucl Med; 1998 Mar; 39(3):547-52. PubMed ID: 9529309
    [Abstract] [Full Text] [Related]

  • 2. Marrow toxicity of 33P-versus 32P-orthophosphate: implications for therapy of bone pain and bone metastases.
    Goddu SM, Bishayee A, Bouchet LG, Bolch WE, Rao DV, Howell RW.
    J Nucl Med; 2000 May; 41(5):941-51. PubMed ID: 10809212
    [Abstract] [Full Text] [Related]

  • 3. Biologic dosimetry of bone marrow: induction of micronuclei in reticulocytes after exposure to 32P and 90Y.
    Lenarczyk M, Goddu SM, Rao DV, Howell RW.
    J Nucl Med; 2001 Jan; 42(1):162-9. PubMed ID: 11197968
    [Abstract] [Full Text] [Related]

  • 4. Marrow-sparing effects of 117mSn(4+)diethylenetriaminepentaacetic acid for radionuclide therapy of bone cancer.
    Bishayee A, Rao DV, Srivastava SC, Bouchet LG, Bolch WE, Howell RW.
    J Nucl Med; 2000 Dec; 41(12):2043-50. PubMed ID: 11138691
    [Abstract] [Full Text] [Related]

  • 5. Radiation absorbed dose estimation for 90Y-DOTA-biotin with pretargeted NR-LU-10/streptavidin.
    Breitz HB, Fisher DR, Goris ML, Knox S, Ratliff B, Murtha AD, Weiden PL.
    Cancer Biother Radiopharm; 1999 Oct; 14(5):381-95. PubMed ID: 10850323
    [Abstract] [Full Text] [Related]

  • 6. Restoration of femoral GM-CFC progenitors in sublethally irradiated mice of various ages treated with liposomal adamantylamide dipeptide.
    Kasná A, Turánek J, Vacek A, Záluská D, Knötigová P, Masek K.
    Int Immunopharmacol; 2004 Aug; 4(8):1099-106. PubMed ID: 15222985
    [Abstract] [Full Text] [Related]

  • 7. [Blood picture changes in rats after 90Y-citrate administration].
    Kutzner J, Eckmann A, Grimm W.
    Nuklearmedizin; 1985 Apr; 24(2):87-9. PubMed ID: 4022786
    [Abstract] [Full Text] [Related]

  • 8. Radiation doses of yttrium-90 citrate and yttrium-90 EDTMP as determined via analogous yttrium-86 complexes and positron emission tomography.
    Rösch F, Herzog H, Plag C, Neumaier B, Braun U, Müller-Gärtner HW, Stöcklin G.
    Eur J Nucl Med; 1996 Aug; 23(8):958-66. PubMed ID: 8753686
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Measurement of pharmacokinetics of yttrium-86 radiopharmaceuticals with PET and radiation dose calculation of analogous yttrium-90 radiotherapeutics.
    Herzog H, Rösch F, Stöcklin G, Lueders C, Qaim SM, Feinendegen LE.
    J Nucl Med; 1993 Dec; 34(12):2222-6. PubMed ID: 8254415
    [Abstract] [Full Text] [Related]

  • 12. Preparation and Dosimetry Evaluation of a Carrier- Free 90Y Labeled DOTMP as a Promising Agent for Bone Marrow Ablation.
    Salek N, Vosoghi S, Arani SS, Samani AB, Mehrabi M, Maraghe MG.
    Curr Radiopharm; 2018 Dec; 11(2):116-122. PubMed ID: 29651974
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Enhanced hematopoietic recovery in irradiated mice pretreated with interleukin-1 (IL-1).
    Schwartz GN, MacVittie TJ, Vigneulle RM, Patchen ML, Douches SD, Oppenheim JJ, Neta R.
    Immunopharmacol Immunotoxicol; 1987 Dec; 9(2-3):371-89. PubMed ID: 3325546
    [Abstract] [Full Text] [Related]

  • 16. Hemopoietic progenitor cells in the blood as indicators of the functional status of the bone marrow after total-body and partial-body irradiation: experiences from studies in dogs.
    Nothdurft W, Kreja L.
    Stem Cells; 1998 Dec; 16 Suppl 1():97-111. PubMed ID: 11012152
    [Abstract] [Full Text] [Related]

  • 17. Radiosensitivity increases with differentiation status of murine hemopoietic progenitor cells selected using enriched marrow subpopulations and recombinant growth factors.
    Baird MC, Hendry JH, Testa NG.
    Radiat Res; 1990 Sep; 123(3):292-8. PubMed ID: 2217726
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The effect of low dose rate on recovery of hemopoietic and stromal progenitor cells in gamma-irradiated mouse bone marrow.
    Gallini R, Hendry JH, Molineux G, Testa NG.
    Radiat Res; 1988 Sep; 115(3):481-7. PubMed ID: 3174931
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.